pharma news

News

Kaken details the data behind its PI3K inhibitor filing

Kaken has revealed the data that supported its recent marketing application for serabelisib as a treatment for vascular malformations in Japan.

News

Precision Neuro breaks new ground in BCI technology

Precision Neuroscience has shown that people can control electronic devices with thought alone, without a need for electrodes implanted in the brain.

News

Gilead, MSD share data on once-weekly oral HIV treatment

Gilead/MSD's once-weekly oral medicine for HIV has been shown to achieve high rates of viral suppression in phase 3, setting up regulatory filings.

News

Trump sets course for 100%, then 200%, tariffs on generics

Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, rising to 200% after a year, in a reshoring push.

News

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

News

Agios shares slide as it abandons sickle cell candidate

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in sickle cell disease.

Kaken details the data behind its PI3K inhibitor filing

Precision Neuro breaks new ground in BCI technology

Gilead, MSD share data on once-weekly oral HIV treatment

Trump sets course for 100%, then 200%, tariffs on generics

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Agios shares slide as it abandons sickle cell candidate

Roche, Viking, and Syntis showcase obesity drug candidates

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks